Opendata, web and dolomites

BQ-Technology

BrainQ, non-invasive, very low intensity, BCI-based frequency dependent electromagnetic field tailored treatment for neuro recovery (BQ).

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 BQ-Technology project word cloud

Explore the words cloud of the BQ-Technology project. It provides you a very rough idea of what is the project "BQ-Technology" about.

treatment    global    clinical    infections    computer    world    paralysed    dependent    variety    bill    frequencies    perform    injuries    anomalous    translated    aging    neural    waves    remarkable    viral    prevalence    risk    living    intelligence    neurological    brainq    spectral    mortality    globally    triggers    revolutionary    demonstrated    uses    agnostic    eeg    efficacy    causes    animal    operated    deficits    skills    recovery    care    time    network    designed    strokes    impaired    operator    connected    back    restore    continue    daily    natural    artificial    decreased    easily    populations    linked    healthcare    trials    55    doubles    algorithms    indication    patterns    death    age    dementia    rehabilitation    interface    stimulation    patients    burden    brain    feet    regain    stroke    cloud    materials    sensorimotor    scalable    impairments    electromagnetic    first    invasive    attributable    device    disability    frequency    bq    functional    patient    human    cognitive    sensor    disorders    decade    proprietary    neuro    motor    treat   

Project "BQ-Technology" data sheet

The following table provides information about the project.

Coordinator
BRAINQ TECHNOLOGIES LTD 

Organization address
address: 4/4 HIGH TECH VILLAGE GIVAT RAM
city: JERUSALEM
postcode: 39129
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Israel [IL]
 Project website http://brainqtech.com/
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-1
 Funding Scheme SME-1
 Starting year 2018
 Duration (year-month-day) from 2018-08-01   to  2018-11-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    BRAINQ TECHNOLOGIES LTD IL (JERUSALEM) coordinator 50˙000.00

Map

 Project objective

The WHO has identified neurological disorders as a major burden and emerging challenge to global healthcare systems. These range from causes such as stroke and dementia, to injuries and viral infections. The prevalence of strokes and dementia are strongly linked to increasing age, for example stroke risk more than doubles every decade after 55 . Although, mortality attributable to stroke has decreased over time Stroke remains a leading cause of death and disability globally and can cause significant deficits in sensorimotor skills and cognitive abilities.

With the increasingly aging populations across the world and particularly in Europe, the burden of care from Neurological disorders is set to continue increasing.

BrainQ’s BQ system is a revolutionary Brain Computer Interface-based stimulation device used to enhance neuro-recovery. Our device uses proprietary, artificial intelligence algorithms to identify anomalous spectral patterns in patient's brain waves (“EEG”). These patterns are then translated into a tailored frequency dependent electromagnetic treatment targeting specific impaired functional neural network associated with these frequencies and triggers natural rehabilitation thus promoting neuro recovery process.

Device is designed to enable non-invasive treatment for motor impairments following a variety of neurological disorders; help patients get back on their feet and restore their ability to perform activities of daily living. Treatment is tailored to each patient, is patient friendly, non-invasive, cloud connected & scalable, with low Bill of Materials, and operator & indication agnostic. This means it is easily operated and can be used to treat a variety of neurological disorders. Pre-clinical animal trials and first-in-human clinical trials have demonstrated remarkable efficacy, allowing paralysed patients regain sensor and motor abilities.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "BQ-TECHNOLOGY" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "BQ-TECHNOLOGY" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

Colourganisms (2020)

Microbial production of custom-made, pure and sustainable anthocyanins

Read More  

TAPPXSSAI (2019)

Development of a system for automatic ad insertion into on-demand streaming video to provide new monetization mechanisms to the media industry

Read More  

BeatsDigTherapeutics (2019)

Project SCALE: Tailored Digital Therapeutics for Neurological and Brain Disorders

Read More